 |
|
|
| |
Reported Safety of HCV Direct-Acting Antivirals With Opioids: 2017 to 2021
|
| |
| |
EASL 2022 June 22-26 London
Anthony Martinez1, Tipu Khan2, Douglas E. Dylla3, Dwaipayan Mukherjee3, Nael M. Mostafa3, Jatinder Kaur3, Dimitri Semizarov3, John Marcinak3, Michelle Collins3, Brad Saget3, Brian Conway4
1Department of Medicine, University at Buffalo, State University of New York, Buffalo, NY, USA; 2Ventura County Medical Center, Ventura, CA, USA; 3AbbVie Inc., North Chicago, IL, USA; 4Vancouver Infectious Diseases Centre, Vancouver, CAN
|
| |
|
|
|
|
|
